Latest Operational Cash Flow News

AIC Mines reports robust production and cash flow from Eloise, advances Jericho development with promising drilling, and kicks off a major processing plant expansion.

VHM Limited has significantly expanded its Exploration Target at the Goschen Project in Victoria, revealing a potential resource of up to 4 billion tonnes of ore rich in valuable heavy minerals and rare earths. This update underscores Goschen's emerging status as a major player in Australia's mineral sands sector.

Orora Limited has finalized its strategic portfolio transformation, delivering solid FY25 financial results despite softness in its glass segment. The company outlines a cautiously optimistic FY26 outlook, underpinned by sustainability progress and investments in beverage packaging innovation.

29Metals maintains steady copper output at Golden Grove despite seismic disruptions to zinc production, while progressing key growth projects and regulatory steps toward Capricorn Copper’s restart.

Sheffield Resources achieved a record quarterly concentrate production at its Thunderbird mine but faces subdued zircon sales due to challenging market conditions in China, withholding December quarter guidance.

Duxton Farms has moved forward with a transformative merger to diversify its agricultural portfolio while navigating a challenging start to FY2026 with dry conditions impacting winter crops.

Baby Bunting has reported record FY25 results and reaffirmed its FY26 guidance, driven by strong sales growth and the ongoing Store of the Future refurbishment program. The company is expanding both large and small format stores, aiming to return to a +10% EBITDA margin business.

Mitchell Services Limited delivered a robust Q1 FY26 performance, marked by a 68% jump in EBITDA and a dramatic 93% reduction in net debt. The company’s strategic investment in a decarbonisation joint venture signals a forward-looking growth trajectory.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Netwealth Group Limited has reported a landmark quarter with total Funds Under Administration soaring to $120.8 billion, driven by record first-quarter net flows of $4.1 billion and strategic service expansions.